SOFIA GOLI: Open Payments
NPI 1780100891 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $496
Food & beverage: $440Education: $56
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
| Amgen Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Organon LLC | 2 | $15 |
Products named: DUPIXENT, FASENRA, NEFFY, Rhapsido, AYVAKIT, TEZSPIRE, AIRSUPRA, Xolair.
Industry payments across CO — which companies pay providers there.
